Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20279)

• Formulation Name: Sitagliptin 25 mg tablet
• Company: Avera McKennan Hospital; Merck Sharp & Dohme

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sitagliptin	(DMGDKXN)	Cystic fibrosis	CA25	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium hydrogenphosphate	(E00294)	24441	Diluent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent